Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact


Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo in 1993 as a first generation internet teaching tool consolidating human embryology teaching for first year medical students.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human.

The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.


WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

December 5, 2012--------News Archive Return to: News Alerts


It's not clear how the genetic regions identified
affect both birth weight and adult metabolism,
although the findings do offer some clues
about the biological pathways involved.








WHO Child Growth Charts

       

Genes Link Fetal Growth with Adult Metabolism and Disease

Researchers have identified four new genetic regions that influence birth weight, providing further evidence that genes as well as maternal nutrition are important for growth in the womb

Three of the regions are also linked to adult metabolism, helping to explain why smaller babies have higher rates of chronic diseases later in life.


It has been known for some time that babies born with
a lower birth weight are at higher risk of chronic diseases
such as type 2 diabetes and cardiovascular disease.

Three genetic regions have already been identified
that influence birth weight, two of which are also linked
to an increased susceptibility to type 2 diabetes.


The latest study analysed almost 70 000 individuals of European, Arab, Asian and African-American descent from across 50 separate studies of pregnancy and birth. Their findings confirmed the three regions previously identified and also revealed four new genetic regions that are associated with birth weight. The study was funded by the Wellcome Trust, the Netherlands Organisation for Scientific Research, the European Union, the Medical Research Council (UK), the Academy of Finland and the National Institutes of Health (USA).


One of the new genetic regions is also associated with
blood pressure in adulthood, providing the first evidence
of a genetic link between birth weight and blood pressure.

Two of the regions are known to be linked to adult
height, showing that genes involved in growth begin
to take effect at a very early stage.


Professor Mark McCarthy, a co-author of the study from the Wellcome Trust Centre for Human Genetics at Oxford, said: "Our findings add to the growing evidence that events during early growth in the womb can have a significant impact on our health as adults. However, these genes tell only part of the story. It's important that we understand how much is down to genetics and how much is due to the environment in which we grow so that we can target efforts to prevent disease later in life."


It's not clear how the genetic regions identified
affect both birth weight and adult metabolism,
although the findings do offer some clues
about the biological pathways involved.

For example, the two genetic regions linking
birth weight with type 2 diabetes risk are also
associated with reduced levels of insulin.

Insulin is the hormone responsible for regulating
sugar levels in the blood, but it is also known
to have an important role in early growth.


Dr Rachel Freathy, co-lead author and a Sir Henry Wellcome Postdoctoral Fellow from the University of Exeter Medical School, said: "These discoveries give us important clues to the mechanisms responsible for the control of a baby's growth in the womb, and may eventually lead to a better understanding of how to manage growth problems during pregnancy."

Together, the newly identified genetic regions have a surprisingly large effect on birth weight when compared with known environmental influences. Dr Inga Prokopenko, co-lead author from the University of Oxford, explained: "Birth weight is subject to powerful influences from many environmental factors. It was a surprise to see that the genetic effects in combination have a similar impact to that of maternal smoking in pregnancy, which itself is well known to lead to lower birth-weight babies."

The findings are published online today in the journal Nature Genetics. The international research team was led by scientists from the UK, Finland, the Netherlands and the USA.

Struan F A Grant, associate director of the Center for Applied Genomics at the Children’s Hospital of Philadelphia and one of the study authors, said: "This study demonstrates that genes acting early in development have important effects on health both in childhood and beyond. While we continue to learn more about the biology, an important implication is that designing prenatal interventions to improve birth weight could have lifelong health benefits."

About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.

About the University of Exeter
The Sunday Times University of the Year 2012-13, the University of Exeter is a Russell Group university and in the top 1 per cent of institutions globally. It combines world-class research with very high levels of student satisfaction. Exeter has over 18,000 students and is ranked seventh in the Sunday Times University Guide, tenth in the UK in the Times Good University Guide 2012 and tenth in the Guardian University Guide. In the 2008 Research Assessment Exercise, 90 per cent of the University's research was rated as being at internationally recognised levels and 16 of its 31 subjects are ranked in the top ten, with 27 subjects ranked in the top 20.

The University has invested strategically to deliver more than £350 million worth of new facilities across its campuses for 2012, including landmark new student services centres - the Forum in Exeter and The Exchange in Cornwall - and world-class new facilities for biosciences, the Business School and the Environment and Sustainability Institute.

About the University of Oxford's Medical Sciences Division
The University of Oxford's Medical Sciences Division is one of the largest biomedical research centres in Europe, with over 2500 people involved in research and more than 2800 students. The University is rated the best in the world for medicine, and it is home to the UK's top-ranked medical school.

From the genetic and molecular basis of disease to the latest advances in neuroscience, Oxford is at the forefront of medical research. It has one of the largest clinical trial portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery.

A great strength of Oxford medicine is its long-standing network of clinical research units in Asia and Africa, enabling world-leading research on the most pressing global health challenges such as malaria, TB, HIV/AIDS and flu. Oxford is also renowned for its large-scale studies which examine the role of factors such as smoking, alcohol and diet on cancer, heart disease and other conditions.

About the Children's Hospital of Philadelphia
The Children’s Hospital of Philadelphia was founded in 1855 as the first paediatric hospital in the United States. Through its long-standing commitment to providing exceptional patient care, training new generations of paediatric healthcare professionals and pioneering major research initiatives, the Children's Hospital has fostered many discoveries that have benefited children worldwide. Its paediatric research programme is among the largest in the nation, ranking third in National Institutes of Health funding. In addition, its unique family-centred care and public service programmes have brought the 516-bed hospital recognition as a leading advocate for children and adolescents.

Original article: http://www.wellcome.ac.uk/News/Media-office/Press-releases/2012/WTP040892.htm